Latest News
The following news articles were published in 2022.
Cancer drug precursor designed to reduce toxic side effects
![Graphical abstract of the work published in the Journal of Medicinal Chemistry [J Med Chem. 2022 Jan 13;65(1):552-561]](https://www.ed.ac.uk/sites/default/files/styles/panel_breakpoints_theme_uoe_tv_1x/public/thumbnails/image/precursor_5fu.png?itok=DBJaJLRu)
Edinburgh researchers developed an orally bioavailable palladium activated 5-Fluorouracil precursor designed to evade anabolic and catabolic drug pathways: March 2022
Loss of Integrin-Linked Kinase sensitizes breast cancer to SRC inhibitors
Our researchers demonstrated that loss of Integrin-Linked Kinase sensitizes triple negative breast cancer to SRC inhibition: February 2022
Trametinib as a new standard of care option for low-grade serous ovarian cancer
Important contributions of Edinburgh investigators to the GOG281/LOGS clinical trial that offers new standard of care option for women with progressive or relapsed low-grade serous ovarian cancer.
Scientists in Scotland to get £12 million boost from Cancer Research UK
The charity has announced that experts in Edinburgh and Glasgow - the Cancer Research UK Scotland Centre - will receive the funding over the next five years for their ground-breaking work as part of a unique chain of cutting-edge research hubs around the UK: February 2022
Live from the Lab with the Brain Tumour Award team
Virtual Lab Tour with Prof Neil Carragher’s Research Group
Zebrafish study unlocks understanding of developmental mechanisms hijacked in cancer
The work, led by Alessandro Brombin and Liz Patton and in collaboration with Tamir Chandra, could potentially inform improved drug therapies for people living with melanoma: January 2022
Disparities in breast cancer care quality have reduced
Regional variation in chemotherapy treatment for breast cancer across Scotland has reduced significantly over the past 15 years, according to a new study: December 2021
TestEd team awarded Principal’s Medal at winter graduation ceremony
Professor Tim Aitman received the medal on behalf of the team for significant achievements in pioneering a way to mass population testing in an epidemic: December 2021
Multi-omic machine learning predictor of breast cancer therapy response
Edinburgh clinicians contributed to a study that developed new AI-based predictor of response to cancer therapy: December 2021